Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile, and molecular biology

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 5, 2000, Pages 1863-1867

  Fardella, Carlos E ^a   Mosso, Lorena ^a   Gómez Sánchez, Celso ^b   Cortés, Paola ^a   Soto, Julia ^a   Gómez, Luis ^a   Pinto, Mauricio ^a   Huete, Alvaro ^a   Oestreicher, Eveline ^a   Foradori, A ^a   Montero, JoaquÍn ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Harry S Truman Veterans Affairs Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

18 HYDROXYHYDROCORTISONE; ALDOSTERONE; DEXAMETHASONE; RENIN; STEROID 11BETA MONOOXYGENASE;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CROSSING OVER; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

ALDOSTERONE; ALDOSTERONE SYNTHASE; BLOOD PRESSURE; CROSSING OVER, GENETIC; DEXAMETHASONE; FEMALE; FLUDROCORTISONE; GLUCOCORTICOIDS; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; MINERALOCORTICOIDS; PREVALENCE; RENIN; SODIUM; STEROID 11-BETA-HYDROXYLASE;

EID: 17744390208     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.5.1863     Document Type: Article

References (50)

1. Incidence of hypertension in the Framingham study
2. Enfermedades crónicas del adulto. Estudio de algunos factores de riesgo en población general urbana de la Regitn Metropohtana, 1986-1987
3. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
4. Molecular biology of mineralocorticoid metabolism
5. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients whit increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: A subtype of EH?
6. Normokalemic primary aldosteronism. A detectable cause of curable "essential" hypertension
7. Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 to 1975
8. Primary aldosteronism. Review article
9. Diagnosis and treatment of primary hyperaldosteronism
10. Evidence that primary aldosteronism may not be uncommon: 12% Incidence among antihypertensive drug trial volunteers
11. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex
12. Cloning and expression of a cDNA for human cytochrome P450aldo as related to primary aldosteronism
13. Aldosterone synthase cytochrome P450 expressed in the adrenals of patients with primary aldosteronism
14. Role of steroid 11β-hydroxylase and 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans
15. Characterization of two genes encoding human steroid 11β-hydroxylase (P45011β)
16. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
17. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossover between CYP11B1 and CYP11B2
18. Artificial mutations in P450c11AS (aldosterone synthase) can increase enzymatic activity: A model for low-renin hypertension?
19. Genetic variation in P450c11AS in Chilean patients with low renin hypertension
20. The aminoacid substitutions Ser288Gly and Val 320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme
21. Hypertension, increased aldosterone secretion, and low plasma renin activity relieved by dexamethasone
22. Dexamethasone-suppressible hyperaldosteronism
23. Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism
24. Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue
25. Elevated urinary excretion of 18-oxocortisol in glucocorticoid-remediable aldosteronism
26. Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism
27. Value of renin measurement, saralasin test, and acelretolol treatment in hypertension
28. Interpretation and guidelines for the use of plasma and urine aldosterone and plasma angiotensin II, angiotensinogen, prorenin, peripheral, and renal vein renin tests
29. Medición de la actividad de renina plasmática a niveles bajos. Optimización del método
30. Diagnosis under random conditions of all disorders of the renin-angiotensinaldosterone axis, including primary hyperaldosteronism
31. Mineralocorticoid hypertension
32. Plasma aldosterone-plasma renin activity ratio: A simple test for primary aldosteronism
33. Biotin-hydrazide derivatives for the development of steroid enzyme-linked inmunoassays
34. Simultaneous measurement of plasma 18-oxocortisol and 18-hydroxycortisol levels in normal man
35. Fludrocortisone suppression test
36. Primary aldosteronism. Part I. Diagnosis of primary hyperaldosteronism
37. Hyperaldosteronism
38. Primary aldosteronism
39. Glucocorticoid-remediable aldosteronism (GRA): Diagnosis, variability of phenotype and regulation of potassium homeostasis
40. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism
41. The adrenals
42. Missence mutation Sr106 → Pro causes 17 α-hydroxylase deficiency
43. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension
44. A mutation in CYP11B1 (Arg 448 → His) associated with steroid 11β-hydroxylase deficiency in Jews of Moroccan origin
45. Primary hyperaldosteronism: A missed diagnosis in "essential hypertensives"?
46. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients
47. Primary aldosteronism: Issues in diagnosis and management
48. Endocrine hypertension
49. Diagnosis of glucocorticoid -remediable aldosteronism in primary aldosteronism: Aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene
50. Glucocorticoid-suppressible aldosteronism: A disorder of the adrenal transitional zone